"Reductil has also been recently withdrawn from sale in Australia, Canada and the United States after a study found it raises the risk of heart attacks and strokes.
A New Zealand study by the Medicines Monitoring Programme at Otago University followed and found the drug to be safer than the initial study had reported."
So what does this mean then - Australia, Canada, and the United States are over-reacting or New Zealand possesses lower standards? The whole article, only a few paragraphs long, does nothing to address the questions that someone taking this would have. I understand that there is a need to "report" these issues but where is the "journalism" here - where is the debate, the statistics, the papers' conclusion or... is that up to the advertisers as well?
No comments:
Post a Comment
For troubleshooting, email: nzreporter@hotmail.com